Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- The physician and the laboratory.Boston Med Surg J. 1922; 187: 324-327
- Use of the laboratory in a teaching hospital: implications for patient care, education, and hospital costs.Ann Intern Med. 1971; 75: 157-163
- Editorial: Routine laboratory tests–the physician's responsibility.N Engl J Med. 1966; 274: 222
- Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits.JAMA. 1998; 280: 550-558
- Contaminant blood cultures and resource utilization. the true consequences of false-positive results.JAMA. 1991; 265: 365-369
- Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study.Crit Care. 2006; 10: R140
- Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction.Arch Intern Med. 2011; 171: 1646-1653
- Do blood tests cause anemia in hospitalized patients? The effect of diagnostic phlebotomy on hemoglobin and hematocrit levels.J Gen Intern Med. 2005; 20: 520-524
- Physician utilization: the state of research about physicians' practice patterns.Med Care. 2002; 40: 1016-1035
- Influencing behavior of physicians ordering laboratory tests: a literature study.Med Care. 1993; 31: 784-794
- Techniques to improve physicians' use of diagnostic tests: a new conceptual framework.JAMA. 1998; 280: 2020-2027
- Influence of educational, audit and feedback, system based, and incentive and penalty interventions to reduce laboratory test utilization: a systematic review.Clin Chem Lab Med. 2015; 53: 157-183
- The impact of residents, interns, and attendings on inpatient laboratory ordering patterns: a report from one university's hospitalist service.Acad Med. 2011; 86: 139-145
- Physician response to surveys. A review of the literature.Am J Prev Med. 2001; 20: 61-67
- Improving house staff ordering of three common laboratory tests. Reductions in test ordering need not result in underutilization.Med Care. 1987; 25: 928-935
- Reducing unnecessary inpatient laboratory testing in a teaching hospital.Am J Clin Pathol. 2006; 126: 200-206
- The impact of peer management on test-ordering behavior.Ann Intern Med. 2004; 141: 196-204
- Administrative change and diagnostic test use. the effect of eliminating standing orders.Med Care. 1984; 22: 569-572
Present affiliations: BMW: Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Mass; AJA: Dana-Farber Cancer Institute, Boston, Mass; JC: Division of Cardiology, Department of Medicine, San Francisco General Hospital University of California; APJ: Department of Neurology and Neurological Surgery, University of Pittsburgh Medical Center, Pa; GM: Intermountain Blood and Marrow Transplant/Acute Leukemia Program, LDS Hospital, Salt Lake City, Utah; SR: Gwinnett Clinic, Lawrenceville, Ga; DPH: Emory University Division of Hospital Medicine, Atlanta, Ga.
Funding: This work was conducted with support from Harvard Catalyst, the Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102), and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.
Conflict of Interest: BMW was paid by the Massachusetts General Hospital Department of Medicine for his work as a research assistant on this study. EAM is supported by National Institutes of Health Grant UL1 TR001102 and is a paid Data and Safety Monitoring Board member of Acorda Therapeutics and Shire Human Genetic Therapies. GM was paid for work for the Blinatumomab Acute Lymphoblastic Leukemia Advisory Board in 2015.
Authorship: All authors had access to the data and played a role in writing this manuscript.